Atlas Trials

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Clinical trial NCT05147233 · COMPLETED

Trial details

NCT number
NCT05147233
Sponsor
Oculis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Inflammation Eye PainPostoperative Cataract
Start date
2022-06-24
Primary completion
2023-06-22
Enrollment
241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.